Diphenylether

Diphenylether

SCHEMBL2438554

BO.c1ccc(Oc2ccccc2)cc1

nearest known ligand 0.80

Full drug profile on Sugi Atlas →

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 6/20 0.80
TSHR P16473 1/20 0.80
NR1H2 P55055 1/20 0.65
BAX Q07812 1/20 0.65
MAOA P21397 1/20 0.57
CA1 P00915 2/20 0.56
CA2 P00918 2/20 0.56
PARP10 Q53GL7 1/20 0.52
SRD5A2 P31213 1/20 0.50
MAOB P27338 1/20 0.50
AKR1C3 P42330 1/20 0.50
FFAR1 O14842 1/20 0.46
IDH1 O75874 1/20 0.46
GSTP1 P09211 1/20 0.46
SOS1 Q07889 1/20 0.46
CA9 Q16790 1/20 0.46
PLA2G2A P14555 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diphenylether SCHEMBL4950525 0.89 LTA4H (1.00) LTA4HTSHRNR1H2BAXMAOA
Diphenylether SCHEMBL12286 0.89 LTA4H (1.00) LTA4HTSHRNR1H2BAXMAOA
Diphenylether SCHEMBL2461810 0.89 LTA4H (1.00) LTA4HTSHRNR1H2BAXMAOA
Diphenylether SCHEMBL9061108 0.89 LTA4H (1.00) LTA4HTSHRNR1H2BAXMAOA
Diphenylether SCHEMBL10597664 0.87 LTA4H (0.80) LTA4HTSHRNR1H2BAXMAOA
Diphenylether SCHEMBL8095335 0.87 LTA4H (0.80) LTA4HTSHRNR1H2BAXMAOA
Diphenylether SCHEMBL27384641 0.87 LTA4H (0.80) LTA4HTSHRNR1H2BAXMAOA
Diphenylether SCHEMBL989476 0.86 LTA4H (0.92) LTA4HTSHRNR1H2BAXMAOA
Diphenylether SCHEMBL10621546 0.86 LTA4H (0.92) LTA4HTSHRNR1H2BAXMAOA
Diphenylether SCHEMBL18096784 0.86 LTA4H (0.92) LTA4HTSHRNR1H2BAXMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8853424-B2 Protein cross-linking inhibitor JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2014-10-07 US disclosed
US-20110212919-A1 PROTEIN CROSS-LINKING INHIBITOR JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2011-09-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110212919-A1 PROTEIN CROSS-LINKING INHIBITOR BAZ2B, PRMT1, BRIX1 LTA4H 4297/4885TSHR 2155/4885NR1H2 4075/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.